LeapZipBlog: Johnson Paul

Johnson Paul's blog

297 blogs

Agriculture Sensors Market (12.5% CAGR) 2018 to 2026: Global Industry Size, Share, Growth, Trends and Forecast

November 13, 2019 by Johnson Paul  

According to a new market report published by Credence Research Inc “Agriculture Sensors Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2026,” the global agriculture sensors market is expected to witness significant growth with increasing deployment of precision agriculture technologies to increase agriculture productivity. Farmers across the world are shifting towards advance agricultural practices from traditional farming methods and adopting modern technologies and equipment to improve yield productivity.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/agriculture-sensors-market

The rising deployment of smart farming practices and advanced monitoring solutions is supporting the demand for sensor solutions in agriculture sector. In addition, manufacturers are focusing on developing sensor solutions for small size farm which is expected to proliferate the demand for sensors in agricultural applications. Moreover, use of sensor technologies in farm machineries, vehicles and farm management systems also expected to support the growth of this market throughout the forecast period. In addition, increasing support from the governments of major agricultural nations to develop essential infrastructure to increase deployment of precision farming technologies is also expected to spur the demand for agriculture sensors throughout the forecast period. The global market for agriculture sensors is expected to cross US$ 2.75 Bn by 2026 at a CAGR of 12.5% throughout the forecast period from 2018 to 2026.

North America is the largest regional market for agriculture sensors market in 2017. Strong government support to increase agriculture production, availability of supporting infrastructure as well as acceptance of smart and precession farming methods increased deployment of advance agriculture solutions in the U.S and Canada. Large size farmers in North America and European countries benefited significantly with the use of precision farming methods and now medium and small size farms are also steadily increasing investment in precision and smart farming methods to increase their productivity. Asia Pacific is expected to witness significant growth throughout the forecast period as major countries are focusing on to increase awareness about the benefits of precision farming methods. India and China are expected to be the major markets for agriculture sensors with presence of large agricultural land and increasing deployment of precision and smart farming methods to meet rising agricultural production demand. 

Yield monitoring is the largest application segment for agriculture sensors. Farmers in developed market are increasingly investing in yield monitoring solutions to monitor crop yield and take necessary decision to increase productivity and reduce loses. Sensors used in irrigation applications are expected to witness considerable growth as farmers across the world are investing in advanced water management solutions.  

The global agriculture sensors industry characterized as fragmented and comprise of large number of local as well as international players in each region. Some major players in the global agriculture sensor market include Texas Instruments Inc, Auroras s.r.l., Robert Bosch GmbH, AG Leader, Avidor High Tech, Libelium Comunicaciones Distribuidas S.L, Ag Leader Technology, Sol Chip Ltd, Pycno Agriculture, CropX Inc, Trimble Inc, Sentera, LLC., The Yield Pty Ltd and others.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59212

Table of Content

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.2.1 Global Agriculture Sensors Market Classification
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
1.3.5 Approach Adopted

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Agriculture Sensors Market
2.2 Global Agriculture Sensors Market, By Sensor Type, 2017
2.3 Global Agriculture Sensors Market, By Application, 2017
2.4 Global Agriculture Sensors Market, By Geography, 2017

Chapter 3 Market Dynamics
3.1 Introduction
3.1.1 Global Agriculture Sensors Market Revenue, 2016 – 2026, (US$ Bn)
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 See-Saw Analysis
3.3.1 Impact Analysis of Drivers and Restraints
3.5 Attractive Investment Proposition
3.6 Value Chain Analysis
3.7 Competitive Landscape
3.7.1 Market Positioning of Key Agriculture Sensors Providers
3.7.2 Leading players’ strategies

Chapter 4 Global Agriculture Sensors Market Analysis, By Sensor Type, 2016 – 2026 (US$ Bn)
4.1 Market Analysis
4.1.1 Global Agriculture Sensors Market, By Sensor Type, 2017 and 2026 (%)
4.2 Physical Sensors
4.2.1 Global Physical Sensors Market, Revenue , 2016 – 2026, (US$ Bn)
4.3 Mechanical Sensors
4.3.1 Global Mechanical Sensors, Revenue , 2016 – 2026, (US$ Bn)
4.4 Chemical Sensors
4.4.1 Global Chemical Sensors Market, Revenue , 2016 – 2026, (US$ Bn)

Chapter 5 Global Agriculture Sensors Market Analysis, By Application, 2016 - 2026 (US$ Bn)
5.1 Market Analysis
5.1.1 Global Agriculture Sensors Market, By Application, 2017 and 2026 (%)
5.2 Yield Monitoring and Mapping
5.2.1 Global Agriculture Sensors Market for Yield Monitoring and Mapping Revenue , 2016 – 2026, (US$ Bn)
5.3 Soil Monitoring
5.3.1 Global Agriculture Sensors Market for Soil Monitoring, Revenue , 2016 – 2026, (US$ Bn)
5.4 Diesease Control and Detection
5.4.1 Global Agriculture Sensors Market for Diesease Control and Detection Revenue , 2016 – 2026, (US$ Bn)
5.5 Diesease Control and Detection
5.5.1 Global Agriculture Sensors Market for Irrigation and Water Management Revenue , 2016 – 2026, (US$ Bn)

Chapter 6 North America Agriculture Sensors Market Analysis, 2016 – 2026, (US$ Bn)
……………

Chapter 7 Europe Agriculture Sensors Market Analysis, 2016 – 2026, (US$ Bn)
…………..

Chapter 8 Asia Pacific Agriculture Sensors Market Analysis, 2016 – 2026, (US$ Bn)
………….

Chapter 9 Rest of the World Agriculture Sensors Market Analysis, 2016 – 2026, (US$ Bn)
………….

Find more research reports on Agriculture Industry, by Credence Research

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/agriculture-sensors-market

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Oncology Biosimilars Market Size, Share, Growth, Trends, Analysis and Forecast 2018 to 2026

November 13, 2019 by Johnson Paul  

The latest market report published by Credence Research, Inc. “Oncology Biosimilars Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global oncology biosimilars market was valued at US$ 1,651.5 Mn in 2017 expanding at a CAGR of 28.3% from 2018 to 2026.

Market Insights

According to the U.S. Food and Drug Administration (FDA), biosimilar is a biological product that is highly similar to an existing, approved reference product and has no clinically meaningful differences. Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. The number of biosimilar approvals soared in the United States as five of nine approved biosimilars across different disease conditions received U.S. FDA approval.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/oncology-biosimilars-market

Furthermore, U.S. witnessed the approvals of oncology biosimilars such as Amgen’s Mvasi (bevacizumab-awwb), a biosimilar to Genentech’s Avastin for the treatment of lung, colorectal, kidney, brain and cervical cancers; and Mylan’s Ogivri (trastuzumab-dkst), a biosimilar to Herceptin for treating breast cancer, gastric cancer, and gastrointestinal cancer. The USFDA is determined to increase biosimilar approvals, especially for cancer as cancer treatment imposes a high cost burden on patients. Although the prices of oncology biosimilars are less compared to biologics, the savings are not on the same scale as compared to generics and patented non-biological drugs. Savings of 20% - 30% compared to the reference biologic product have been observed in major markets such as Europe and North America, making biosimilars as a lucrative alternative.

In terms of drug class, the granulocyte colony-stimulating factor (G-CSF) held the largest share in the oncology biosimilars market owing to its early approvals in Europe and U.S. However, monoclonal antibodies class expected to grow at a highest growth rate and emerge as the largest market in 2026 due to recent approvals of Mvasi (bevacizumab-awwb) and Ogivri (trastuzumab-dkst) in the United States. Moreover, robust pipeline and patent expiration of major biologics during the forecast period would further assist the market growth of monoclonal antibodies. In terms of disease condition, neutropenia led the market due to approvals of filgrastim and Peg-filgrastim to multiple pharmaceutical companies in Europe and Asia Pacific. However, breast cancer is projected to proliferate at a humungous rate due to high prevalence of breast cancer globally and recent approval of trastuzumab in Europe and North America.

Europe dominated the global oncology biosimilars market in 2017 due to presence of approved oncology biosimilar such as filgrastim, trastuzumab and rituximab in the region. Moreover, the European Medicines Agency (EMA) have put forth guidelines for the approval of biosimilars through regulatory bodies such as European Society of Medical Oncology (ESMO). North America is anticipated to exhibit rapid growth in oncology biosimilars market due to market entry of breakthrough oncology biosimilars and vigorous pipeline expected to hit the market during the forecast period. The prominent players actively engaged in the oncology biosimilars market are Samsung Bioepis, Celltrion Inc., Biocon, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., STADA Arzneimittel AG, Pfizer Inc., Sandoz Inc., Teva Pharmaceutical Industries Ltd., Apotex Inc., and BIOCAD. Robust pipeline and ongoing clinical trials in U.S. and Europe are driving the oncology biosimilars market. For instance, Pfizer has six biosimilars in phase III of clinical trials, testing for drugs such as Rituxan/MabThera, Herceptin, Avastin and Humira

Key Market Movements:

  • Rising prevalence of cancer worldwide
  • Recent FDA approved biosimilars contributing towards the growth of oncology biosimilars market
  • Patent expirations of major biologics leading to inclination of generic pharmaceutical companies to venture in biosimilars
  • Partnerships and collaboration between biopharmaceutical companies to increase research and development of biosimilars
  • Robust pipeline of oncology biosimilars anticipated to enter the market by 2020 will also assist market growth

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59205

Table of Content

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Oncology Biosimilars Market Portraiture
2.2. Global Oncology Biosimilars Market, by Drug Class, 2017 (US$ Mn)
2.3. Global Oncology Biosimilars Market, by Disease Condition, 2017 (US$ Mn)
2.4. Global Oncology Biosimilars Market Share, by Geography, 2017 (US$ Mn)

Chapter 3. Oncology Biosimilars: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Oncology Biosimilars Market, by Key Players, 2017

Chapter 4. Global Oncology Biosimilars Market, by Drug Class, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Monoclonal Antibodies
4.3. Granulocyte Colony-Stimulating Factor (G-CSF)
4.4. Pipeline Analysis
4.4.1. Phase III Drug Analysis
4.4.1.1. Rituximab Biosimilar
4.4.1.2. Trastuzumab Biosimilar
4.4.1.3. Filgrastim Biosimilar
4.4.1.4. Bevacizumab Biosimilar
4.4.2. Tabular Representation of Phase I and Phase II Drugs

Chapter 5. Global Oncology Biosimilars Market, by Disease Condition, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Breast Cancer
5.3. Lung Cancer
5.4. Colorectal Cancer
5.5. Cervical Cancer
5.6. Blood Cancer
5.7. Neutropenia
5.8. Others (Brain Cancer, Stomach Cancer, etc.)

Chapter 6. Global Oncology Biosimilars Market, by Geography, 2016 – 2026 (US$ Mn)
……………….

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/oncology-biosimilars-market

Find more research reports on Pharmaceuticals Industry, by Credence Research

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

LED Tube Lights Market (15.2% CAGR) 2018 to 2026: Global Industry Size, Share, Growth, Trends and Forecast

November 13, 2019 by Johnson Paul  

According to a new market report published by Credence Research Inc “LED Tube Lights Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2026,” the global LED Tube Lights market worldwide was valued at US$ 3,705.0 Mn in 2017 and is set to cross US$ 13,000.0 Mn by 2026, growing with a CAGR of 15.2% during the forecast from 2018 to 2026.

The demand for LED tube lights is growing considerably as these tubes offer smooth, constant and clear supply of light and consumes less power. Owing to their long life and higher efficiency these lighting tubes are rapidly replacing traditional fluorescent tube lights in residential and commercial applications. One of the most prominent factors driving the global LED tube lights market growth is the stringent energy consumption regulations being implemented in all major countries across the world. Moreover, the fact that LED tube lights offer high efficiency is another important factor leading to its increased adoption. Therefore, these factors are expected to drive the demand for LED tube lights during the forecast period from 2018 to 2026. However, high initial cost of LED tube lights is one of the restraining factors impacting the market growth negatively. 

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/led-tube-lights-market

In 2017, the residential segment held the largest share in the overall tube lights market. Stringent consumption regulations introduced by major countries across the world coupled with incentives offered on less energy consumption is expected to drive the demand for LED tube lights. Moreover, shorter payback time is another prominent factor which has led to the increasing adoption of LED tube lights across the residential segment. Therefore, on account of the aforementioned factors, the residential segment expected to maintain its dominance throughout the forecast period from 2018 to 2026. With new commercial construction projects, the segment would exhibit robust growth during forecasted period. Architectural sector is the early adopter of LED tube lights in the U.S. and European countries. With consistently declining prices of LED tube lights, architectural sector have reached more than 70% shares of commercial LED lighting usage. 

In 2017, the U.S. LED tube lights market was dominated by ‘up to 5’ feet segment. In addition, the segment is predicted to continue its dominating position over the forecast period from 2018 to 2026. One of the most prominent factors aiding the ‘up to 5 feet’ segment growth is the fact that these tube lights are increasingly used for lighting purposes of comparatively smaller areas. These tube lights find application in offices, houses, educational institutes and retails stores among others. The 5 feet to 10 feet segment on account of its ability to be used for covering both smaller as well as larger areas expected to be the fastest growing segment during the forecast period. 

The internal rivalry amongst the LED tube light manufacturers is high considering the similar type of product offering. Moreover, similar price offering further intensifies the competition and often leads to price war. In addition, with a growing share of LED lighting over the overall lighting market, internal rivalry among competitors expected to be high during the forecast period. Considering the enormous potential in the LED lighting industry, an increasing number of manufacturers are expected to venture into the market in the coming years. Some major players operating in the global LED tube light industry include Koninklijke Philips N.V., Cree, Inc, LG Electronics Inc., GE Lighting, Hubbell Incorporated, Cooper Industries, Samsung LED, Acuity Brands, Inc, Lighting Science Group Corp, Panasonics Corp, Eaton Lighting and OSRAM Licht AG among others.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59198

Table of Content

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
1.3.5 Approach Adopted

Chapter 2 Executive Summary
2.1 Market Snapshot: Global LED Tube Lights Market
2.2 Global LED Tube Lights Market, By Size
2.3 Global LED Tube Lights Market, By Application

Chapter 3 Market Dynamics
3.1 Introduction
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Stringent Energy Consumption Regulations
3.2.1.2 High Efficiency of LED Tube Lights
3.2.2 Market Challenges
3.2.2.1 High Initial Cost of LED Tube Lights
3.3 See-Saw Analysis
3.3.1 Impact Analysis of Drivers and Challenges
3.4 Attractive Investment Proposition, 2017
3.5 Value Chain Analysis
3.6 Porter’s Five Forces Analysis
3.7 Competitive Landscape
3.7.1 Market Positioning of LED Tube Lights Manufacturers in Global
3.7.2 Major Strategies Adopted by Leading Players
3.7.3 Approximate revenue of leading LED tube light manufacturers

Chapter 4 Global LED Tube Lights Market Analysis, By Size
4.1 Market Analysis
4.1.2 Global LED Tube Lights Market Value Share, By Size, 2017 & 2026 (%)
4.2 Up to 5 feet
4.2.1 Global LED Tube Lights (Up to 5 feet) Market Value & Volume, 2016 – 2026, (US$ Mn) (Mn Units)
4.3 5.1 feet to 10 feet
4.3.1 Global LED Tube Lights (5.1 feet to 10 feet) Market Value & Volume, 2016 – 2026, (US$ Mn) (Mn Units)
4.4 More than 10 feet
4.4.1 Global LED Tube Lights (More than 10 feet) Market Value & Volume, 2016 – 2026, (US$ Mn) (Mn Units)

Chapter 5 Global LED Tube Lights Market Analysis, By Application
5.1 Market Analysis
5.1.1 Global LED Tube Lights Market Share, By Application, 2017 & 2026 (%)
5.2 Residential
5.2.1 Global Residential LED Tube Lights Market Value & Volume, 2016 – 2026, (US$ Mn) (Units)
5.3 Commercial
5.3.1 Global Commercial LED Tube Lights Market Value & Volume, 2016 – 2026, (US$ Mn) (Units)
5.4 Industrial
5.4.1 Global Industrial LED Tube Lights Market Value & Volume, 2016 – 2026, (US$ Mn) (Units)

Chapter 6 North America LED Tube Lights Market, 2016 – 2026
…………

Chapter 7 Europe LED Tube Lights Market, 2016 – 2026
………..

Chapter 8 Asia Pacific LED Tube Lights Market, 2016 – 2026
………..

Chapter 9 Rest of the World LED Tube Lights Market, 2016 – 2026
………….

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/led-tube-lights-market

Find more research reports on Semiconductors & Electronics Industry, by Credence Research

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

 

Smart Coatings Market: Global Industry Size, Share, Growth, Trends, Analysis and Forecast 2018 to 2026

November 13, 2019 by Johnson Paul  

According to the latest report published by Credence Research, Inc. “Global Smart Coatings Market By Coating Type (Anti-Corrosion, Anti-Microbial, Self-Cleaning, Self-Healing, Others), By End-Use Industry (Automotive & Transportation, Construction, Consumer Electronics, Aerospace & Defense, Marine, Others) - Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global Smart Coatings market was valued at US$ 2,257.5 Mn in 2017, expected to show the CAGR of 20.5% from 2018 to 2026.

Market Insights

Smart Coatings market size was valued at US$ 2,257.5 Mn in 2017, growing with a CAGR of 20.5% during the forecast period from 2018 to 2026. Smart coatings are custom prepared to meet the varying demand from end-use industries such as automotive & transportation, construction, consumer electronics, aerospace & defense, marine, etc. Their ability to respond quickly to external stimuli and rising application in different end-use industries owing to their outstanding features are the key factors driving the market.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/smart-coatings-market

Features such as self-cleaning, corrosion resistance, color switch, etc. are obtained by the use of various nanomaterial such as carbon black, organic-inorganic hybrid polymers, tungsten oxide, zinc or aluminum coated with nano-TiO2, etc. to achieve higher opacity, better interaction between coating and surface and higher durability of the coating. Although, the smart coating is the niche market, however, improved products demand from customers has catapulted its demand. Smart coatings are gaining traction with the advent of new technologies such as nanotechnology, conductive materials, and micro-encapsulation, self-healing and self-assembling systems, further enhancing their functionalities. These technologies are enabling coatings to deliver added performance beyond aesthetics and protection. Constant R&D by the leading players have resulted in the development of lightweight and eco-friendly smart coatings, thereby further boosting the market. However, slow mass adoption due to the high cost of these multifunctional coating may act as a restraining factor for Smart Coatings market

Based on the geography, North America held the largest share in the global Smart Coatings market in 2017 in terms of value and volume as many key players are headquartered in the region. Whereas, Asia-Pacific is the fastest growing region owing to rising population and disposable income coupled with growth in the manufacturing sector are some of the major factors for growth of Asia-Pacific Smart Coatings market.

Automotive & transportation was the leading end-use industry in terms of volume consumption in 2017. This is attributed to rising application of smart coatings in the exterior application in the automotive industry owing to advanced properties such as anti-corrosion, self-cleaning, and self-healing. By type, anti-corrosion coatings accounted for the largest market share in 2017, owing to its wide acceptance in the two major end-use industries; automotive & transportation and construction across the globe. Furthermore, the rapid expansion of applications of smart coatings in end-use industries such as textile, healthcare, energy, etc. has resulted in the growth of the Smart Coatings market in this region.

Key players operating in the global Smart Coatings market includes 3M Company (U.S.), The Dow Chemical Company (U.S.), The Sherwin-Williams Company (US), RPM International (US), Axalta Coatings Systems (US),  AkzoNobel N.V. (Netherlands), Hempel A/S (Denmark), Jotun A/S (Norway), NEI Corporation (US), and PPG Industries (US).

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59183

Table of Content

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offering
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Market Size Estimation
1.3.3.1. Top-Down Approach
1.3.3.2. Bottom-Up Approach
1.3.4. Phase III- Expert Panel Review
1.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Smart Coatings Market Snapshot
2.2. Global Smart Coatings Market by Coating Type, 2017 (Kilo Ton, US$ Mn)
2.3. Global Smart Coatings Market, by End-use Industry, 2017 (Kilo Ton, US$ Mn)
2.4. Global Smart Coatings Market, by Geography, 2017 (Kilo Ton, US$ Mn)

Chapter 3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growing Demand from Asia-Pacific’s End-use Industries
3.2.1.2. Advanced Performance Delivery from Smart Coatings
3.2.2. Restraints
3.2.2.1. Strict Environment Regulations
3.2.2.2. Restraint 2
3.2.3. Opportunities
3.2.3.1. Increasing Demand for Products Requiring Low Maintenance
3.2.3.2. Opportunity 2
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape: Market Positioning of Key Players, 2017

Chapter 4. Global Smart Coatings Market, by Coating Type, 2016 – 2026 (Kilo Ton, US$ Mn)
4.1. Overview
4.1.1. Global Smart Coatings Market Share Analysis, by Coating Type, 2017 vs. 2026 (Value, %)
4.1.2. Global Smart Coatings Market, by Coating Type, 2016-2026 (Kilo Ton, US$ Mn)
4.2. Anti-corrosion
4.3. Anti-microbial
4.4. Self-cleaning
4.5. Self-healing
4.6. Others (self-dimming, color shifting, photovoltaic, piezoelectric, etc.)

Chapter 5. Global Smart Coatings Market, by End-use Industry, 2016 – 2026 (Kilo Ton, US$ Mn)
5.1. Overview
5.1.1. Smart Coatings Market Share Analysis, by End-use Industry, 2017 vs. 2026 (Value, %)
5.1.2. Global Smart Coatings Market, by End-use Industry, 2016-2026 (Kilo Ton, US$ Mn)
5.2. Automotive & Transportation
5.3. Construction
5.4. Consumer Electronics
5.5. Aerospace & Defense
5.6. Marine
5.7. Others (consumer goods, energy, healthcare, etc.)

Chapter 6. Global Smart Coatings Market, by Geography, 2016 – 2026 (Kilo Ton, US$ Mn)
……………….

Blog Medium: https://medium.com/@kumarganeshtr/smart-coatings-market-20-5-92d94d19b255

Find more research reports on Chemicals Industry, by Credence Research

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Natural and Organic Personal Care Market Size, Share, Growth and Forecast 2018 to 2026

November 13, 2019 by Johnson Paul  

According to the latest report published by Credence Research, Inc. “Global Natural and Organic Personal Care Market - Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global natural and organic market accounted for US$ 11,504.9 Mn in 2017, expanding at a CAGR of 11.1% from 2018 to 2026. 

Market Insights

The global natural and organic personal care market was pegged at US$ 11504.9 Mn in 2017 growing with a CAGR of 11.1% during the forecast period from 2018 to 2026. Natural and organic personal care products contain certified organic ingredients and are basically derived from natural ingredients and plant extracts. Varying climatic conditions followed by shorter life cycles of organic and personal care products, and dynamic attributes of personal care manufacturers to keep pace with growing market demand; manufacturers are focusing on launching, marketing and presentation of innovative natural and personal care products that in turn is expected to propel the market demand during the forecast period.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/natural-and-organic-personal-care-market

Rising number of natural and organic personal care products with herbal extracts and antioxidant properties is also fuelling the growth of this market .The market is projected to grow at a consistent rate owing to the increase in shelf space and retail stores globally. Moreover, increasing number of aging female population followed by increased purchasing power of women aged twenty-five and above is also expected to drive the demand for various anti-aging products that includes moisturizers, creams, and anti-hair fall products. However, owing to fluctuating price of raw materials, cost–intensive product certification process followed by labor intensive production processes, these products are premium priced and are costlier than synthetic personal care products which in turn is expected to restrain the growth of natural and organic personal care market during the forecast period.

The overall natural and organic personal care market is segmented based on product type, distribution channel and geography. In 2017, in terms of product type, hair care segment dominated the global natural and organic personal care market with around 30 % value share and projected to maintain its dominant position throughout the forecast period. Trend shows that manufacturers are focusing on using organic ingredients in hair care products that includes coconut, marula, argan, and almond among others owing to the rising awareness of consumers related to the wide usage of harmful chemicals used in hair care products .This factor expected to drive the demand for hair care segment during the forecast period. By distribution channel, hypermarket/supermarket held the largest market share in 2017. Distribution through hypermarket and supermarket is a key success factor in natural and organic personal care market. The manufacturers are shifting to mainstream mass retailers that includes hypermarkets and supermarkets from niche distribution channel due to the increasing consumer demand for natural and organic personal care products. Hypermarkets such as Target Brands, Inc. and Walmart Stores, Inc. followed by supermarkets that includes Safeway Inc. and Loblaw Companies Limited are focusing on expanding their product portfolio and introducing innovative natural and organic personal care products in their current product portfolio. All these factors are expected to boost the demand for hypermarket /supermarket segment during the forecast period.

By geography, North America held the largest share in the global natural and organic personal care market followed by Europe and Asia Pacific. Consumers’ expanding interest in wellness that includes self-care and nutrition is the prime factor augmenting the demand for this market. In addition, presence of large conglomerates in this region that includes Procter and Gamble and the Estée Lauder Companies Inc., among others is also acting as a driving factor in the growth of natural and organic personal care market in this region. In 2017, Asia Pacific was the fastest growing region owing to the increasing demand and consumption of natural and organic hair care and skin care products in India and China. In addition, smart phone penetration followed by ecommerce is also boosting the demand for this market as consumers in this region are more inclined towards buying personal care products via ecommerce by using their smart phones.                      

Key market players in the global natural and organic personal care market include Loreal SA, Kao Corporation, Kiehl’s, Jonhson and Jonhson Consumer Inc., The Hain Celestial Group, Natura Cosméticos S.A., Estée Lauder Companies Inc and Procter and Gamble among others.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59147

Table of Content

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offering
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Top Down and Bottom Up Approach
1.3.3.1. Top-Down Approach
1.3.3.2. Bottom-Up Approach
1.3.4. Phase III- Expert Panel Review
1.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Natural & Organic Personal Care Market Snapshot
2.2. Global Natural & Organic Personal Care Market by Product Type, 2017 (US$ Mn)
2.3. Global Natural & Organic Personal Care Market, by Distribution Channel, 2017 (US$ Mn)
2.4. Global Natural & Organic Personal Care Market, by Geography, 2017 (Kilo Ton US$ Mn)

Chapter 3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Increasing demand for natural ingredients in cosmetics
3.2.1.2. Driver 2
3.2.2. Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape: Market Positioning of Key Players, 2017

Chapter 4. Global Natural & Organic Personal Care Market, by Product Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.1.1. Global Natural & Organic Personal Care Market Share Analysis, by Product Type, 2017 vs. 2026 (Value, %)
4.1.2. Global Natural & Organic Personal Care Market, by Product Type, 2016-2026 (US$ Mn)
4.2. Skin Care
4.3. Hair Care
4.4. Oral Care
4.5. Cosmetics
4.6. Others (Deodorants, Toiletries, and Female Hygiene Products)

Chapter 5. Global Natural & Organic Personal Care Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
5.1. Overview
5.1.1. Natural & Organic Personal Care Market Share Analysis (Value, %), by Distribution Channel, 2017 vs. 2026
5.1.2. Global Natural & Organic Personal Care Market Value, by Distribution Channel, 2016-2026 (US$ Mn)
5.2. Hypermarket/Supermarket
5.3. Specialist Retailers
5.4. Drug Stores
5.5. Online Retailing
5.6. Direct Selling

Chapter 6. Global Natural & Organic Personal Care Market, by Geography, 2016 – 2026 (US$ Mn)
……………..

Blog Medium: https://medium.com/@kumarganeshtr/natural-and-organic-personal-care-market-size-share-growth-trends-analysis-and-forecast-2018-db920920cd7

Find more research reports on Consumer Goods Industry, by Credence Research

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Tumor Necrosis Factor (TNF) Inhibitors Market Size, Share, Growth, Trends, Analysis and Forecast 2018 to 2026

November 13, 2019 by Johnson Paul  

The latest market report published by Credence Research, Inc. the tumor necrosis factor inhibitors market was valued at US$ 43,394.4 Mn in 2017 and expected to reach US$ 181,139.7 Mn by 2026, expanding at a CAGR of 16.5 % from 2018 to 2026.

Market Insights

Global tumor necrosis factor (TNF) inhibitor market was valued at US$ 43,394.4 Mn in 2017 and projected to reach US$ 181,139.7 by 2026 with a CAGR of 16.5% during the forecast period. Only five approved TNF inhibitors dominate the current market namely, adalimumab, certolizumab, etanercept, golimumab and infliximab. The extensive application of these approved drugs for various autoimmune conditions ensures continuous market growth during the forecast period from 2018 to 2026. Approval of biosimilars would further add to the lucrativeness of this market. Biosimilars will intensify the market competition in TNF inhibitors market as several industrial players are currently investing in their development. High prevalence of chronic conditions such as Crohn’s disease, ulcerative colitis, plaque psoriasis, rheumatoid arthritis & others, continuous research activities in developing target-based biologics, provision of structured reimbursement policies and growing inclination towards cost-efficient biosimilars in developing economies contribute to the remunerative growth of this market. Additionally, rising prevalence of chronic autoimmune disease such as Crohn’s disease, rheumatoid arthritis, plaque psoriasis and ulcerative colitis increase the need for target based therapies such as TNF inhibitors.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/tumor-necrosis-factor-tnf-inhibitors-market

TNF inhibitors market has been segmented based on drug type which comprises approved TNF inhibitors as mentioned above and various applications of TNF inhibitors namely, Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ulcerative colitis, ankylosing spondylitis, hidradenitis suppurativa, uveitis and juvenile arthritis. Crohn’s disease segment projected with fastest CAGR owing to its growing prevalence across geographies and rising awareness on the efficiency of TNF inhibitors. As per the Centers for Disease Control and Prevention (CDC), around 201 cases of Crohn’s disease per 100,000 adults observed in 2015. The prevalence will grow further during the forecast period owing to growing adoption of unhealthy dietary habits.

Based on geographical demarcation, North America dominated the market in 2017 with a market share of over 40% and expected to maintain this position throughout the forecast period. Patent exclusivity of approved TNF inhibitors for longer duration ensures maximum lucrativeness in this market. Asia Pacific exhibited fastest growth during the forecast period. Increase in prevalence of autoimmune diseases, rising awareness on efficacy and availability of TNF inhibitors, growing investments of various industrial players in biosimilars and increased support from regulatory boards for biosimilar approval is expected to catalyze the overall market growth in Asia Pacific.

TNF inhibitors market comprise of industrial players with maximum global outreach namely, Abbvie, Inc., Amgen, Inc., Biocad Biopharmaceutical Co., Boehringer Ingelheim Pharmaceuticals, Inc., EPIRUS Biopharmaceuticals, Inc., Innovent Biologics, Inc., Janssen Biotech, Inc., Merck & Co., Inc., Novartis A.G., Pfizer, Inc., Shanghai Henlius Biotech, Inc. and UCB S.A.

Key Market Movements:

  • Globally tumor necrosis factor inhibitors market witnesses a remunerative growth with a CAGR of 16.5 % during the forecast period from 2018 to 2026
  • Constant research activities in label expansion of TNF inhibitors enhancing its application across various disease areas thus catalyzing the market growth
  • Rising prevalence of autoimmune disease across geographies and the use of TNF inhibitors for multiple autoimmune conditions catalyzing the market growth
  • Biosimilars are expected to increase market competition in the near future and ensure incessant growth  during the forecast period from 2018 to 2026

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59105

Table of Content

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Tumor Necrosis Factor Inhibitors Market Portraiture
2.2. Tumor Necrosis Factor Inhibitors Market, by Drug Type, 2017 (US$ Mn)
2.3. Tumor Necrosis Factor Inhibitors Market, by Application, 2017 (US$ Mn)
2.4. Tumor Necrosis Factor Inhibitors Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Tumor Necrosis Factor Inhibitors Market: Dynamics and Future Outlook
3.1. Overview
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Increased Prevalence of Autoimmune Diseases
3.2.1.2. Continuous Development of Biosimilars
3.2.2. Market Challenges
3.2.2.1. Challenge 1
3.2.3. Market Opportunities
3.2.3.1. Regulatory Support for Development of Biosimilars
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Tumor Necrosis Factor Inhibitors Market, by Drug Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Adalimumab (Humira)
4.3. Certolizumab (Cimzia)
4.4. Etanercept (Enbrel)
4.5. Golimumab (Simponi)
4.6. Infliximab (Remicade)
4.7. Pipeline Analysis
4.7.1. Phase III Molecules (Forecast till 2026 in US$ Mn)
4.7.1.1. IBI303
4.7.1.2. HLX03
4.7.1.3. BCD-057
4.7.1.4. M923
4.7.2. Phase I & Phase II Molecules (Tabular Representation)

Chapter 5. Global Tumor Necrosis Factor Inhibitors Market, by Application, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Crohn’s Disease
5.3. Rheumatoid Arthritis
5.4. Psoriatic Arthritis
5.5. Plaque Psoriasis
5.6. Ulcerative Colitis
5.7. Ankylosing Spondylitis
5.8. Hidradenitis Suppurativa
5.9. Uveitis
5.10. Juvenile Arthritis

Chapter 6. Global Tumor Necrosis Factor Inhibitors Market, by Geography, 2016 – 2026 (US$ Mn)
…………

Blog Medium: https://medium.com/@kumarganeshtr/tumor-necrosis-factor-tnf-inhibitors-market-16-5-6badc9ce223c

Find more research reports on Pharmaceuticals Industry, by Credence Research

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Tumor Necrosis Factor (TNF) Inhibitors Market Size, Share, Growth, Trends, Analysis and Forecast 2018 to 2026

November 13, 2019 by Johnson Paul  

The latest market report published by Credence Research, Inc. the tumor necrosis factor inhibitors market was valued at US$ 43,394.4 Mn in 2017 and expected to reach US$ 181,139.7 Mn by 2026, expanding at a CAGR of 16.5 % from 2018 to 2026.

Market Insights

Global tumor necrosis factor (TNF) inhibitor market was valued at US$ 43,394.4 Mn in 2017 and projected to reach US$ 181,139.7 by 2026 with a CAGR of 16.5% during the forecast period. Only five approved TNF inhibitors dominate the current market namely, adalimumab, certolizumab, etanercept, golimumab and infliximab. The extensive application of these approved drugs for various autoimmune conditions ensures continuous market growth during the forecast period from 2018 to 2026. Approval of biosimilars would further add to the lucrativeness of this market. Biosimilars will intensify the market competition in TNF inhibitors market as several industrial players are currently investing in their development. High prevalence of chronic conditions such as Crohn’s disease, ulcerative colitis, plaque psoriasis, rheumatoid arthritis & others, continuous research activities in developing target-based biologics, provision of structured reimbursement policies and growing inclination towards cost-efficient biosimilars in developing economies contribute to the remunerative growth of this market. Additionally, rising prevalence of chronic autoimmune disease such as Crohn’s disease, rheumatoid arthritis, plaque psoriasis and ulcerative colitis increase the need for target based therapies such as TNF inhibitors.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/tumor-necrosis-factor-tnf-inhibitors-market

TNF inhibitors market has been segmented based on drug type which comprises approved TNF inhibitors as mentioned above and various applications of TNF inhibitors namely, Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ulcerative colitis, ankylosing spondylitis, hidradenitis suppurativa, uveitis and juvenile arthritis. Crohn’s disease segment projected with fastest CAGR owing to its growing prevalence across geographies and rising awareness on the efficiency of TNF inhibitors. As per the Centers for Disease Control and Prevention (CDC), around 201 cases of Crohn’s disease per 100,000 adults observed in 2015. The prevalence will grow further during the forecast period owing to growing adoption of unhealthy dietary habits.

Based on geographical demarcation, North America dominated the market in 2017 with a market share of over 40% and expected to maintain this position throughout the forecast period. Patent exclusivity of approved TNF inhibitors for longer duration ensures maximum lucrativeness in this market. Asia Pacific exhibited fastest growth during the forecast period. Increase in prevalence of autoimmune diseases, rising awareness on efficacy and availability of TNF inhibitors, growing investments of various industrial players in biosimilars and increased support from regulatory boards for biosimilar approval is expected to catalyze the overall market growth in Asia Pacific.

TNF inhibitors market comprise of industrial players with maximum global outreach namely, Abbvie, Inc., Amgen, Inc., Biocad Biopharmaceutical Co., Boehringer Ingelheim Pharmaceuticals, Inc., EPIRUS Biopharmaceuticals, Inc., Innovent Biologics, Inc., Janssen Biotech, Inc., Merck & Co., Inc., Novartis A.G., Pfizer, Inc., Shanghai Henlius Biotech, Inc. and UCB S.A.

Key Market Movements:

  • Globally tumor necrosis factor inhibitors market witnesses a remunerative growth with a CAGR of 16.5 % during the forecast period from 2018 to 2026
  • Constant research activities in label expansion of TNF inhibitors enhancing its application across various disease areas thus catalyzing the market growth
  • Rising prevalence of autoimmune disease across geographies and the use of TNF inhibitors for multiple autoimmune conditions catalyzing the market growth
  • Biosimilars are expected to increase market competition in the near future and ensure incessant growth  during the forecast period from 2018 to 2026

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59105

Table of Content

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Tumor Necrosis Factor Inhibitors Market Portraiture
2.2. Tumor Necrosis Factor Inhibitors Market, by Drug Type, 2017 (US$ Mn)
2.3. Tumor Necrosis Factor Inhibitors Market, by Application, 2017 (US$ Mn)
2.4. Tumor Necrosis Factor Inhibitors Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Tumor Necrosis Factor Inhibitors Market: Dynamics and Future Outlook
3.1. Overview
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Increased Prevalence of Autoimmune Diseases
3.2.1.2. Continuous Development of Biosimilars
3.2.2. Market Challenges
3.2.2.1. Challenge 1
3.2.3. Market Opportunities
3.2.3.1. Regulatory Support for Development of Biosimilars
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Tumor Necrosis Factor Inhibitors Market, by Drug Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Adalimumab (Humira)
4.3. Certolizumab (Cimzia)
4.4. Etanercept (Enbrel)
4.5. Golimumab (Simponi)
4.6. Infliximab (Remicade)
4.7. Pipeline Analysis
4.7.1. Phase III Molecules (Forecast till 2026 in US$ Mn)
4.7.1.1. IBI303
4.7.1.2. HLX03
4.7.1.3. BCD-057
4.7.1.4. M923
4.7.2. Phase I & Phase II Molecules (Tabular Representation)

Chapter 5. Global Tumor Necrosis Factor Inhibitors Market, by Application, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Crohn’s Disease
5.3. Rheumatoid Arthritis
5.4. Psoriatic Arthritis
5.5. Plaque Psoriasis
5.6. Ulcerative Colitis
5.7. Ankylosing Spondylitis
5.8. Hidradenitis Suppurativa
5.9. Uveitis
5.10. Juvenile Arthritis

Chapter 6. Global Tumor Necrosis Factor Inhibitors Market, by Geography, 2016 – 2026 (US$ Mn)
…………

Blog Medium: https://medium.com/@kumarganeshtr/tumor-necrosis-factor-tnf-inhibitors-market-16-5-6badc9ce223c

Find more research reports on Pharmaceuticals Industry, by Credence Research

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Biologics Market (9.5% CAGR) 2018 to 2026: Global Industry Size, Share, Growth, Trends and Forecast

November 13, 2019 by Johnson Paul  

The latest market report published by Credence Research, Inc. the biologics market was valued at US$ 254.9 Bn in 2017, and expected to reach US$ 580.5 Bn by 2026 at a CAGR of 9.5 % during the forecast period from 2018 to 2026.

Market Insights

Global biologics market exhibits remunerative growth during the forecast period from 2018 to 2026 due to presence of around 800 biologics in pipeline. The growth attributed is due to incessant expansion in product portfolio with increasing demand for biologics across the globe. Rising prevalence of chronic diseases, unremitting research and development activities and continuous investment in biologics contribute to the overall market growth. According to World Health Organization (WHO), by 2020 chronic diseases would account for 75% of deaths globally.  Cancer, autoimmune diseases, and diabetes contribute above 60% of the overall biologics market. In 2016, approximately 50% of new molecular entities approved by the FDA were biologics. Continuous development in cellular & gene therapy further catalyzes the market owing to its high efficacy and therapeutic outcome. CAR-T cell therapies are the latest therapies approved by the FDA for oncology indications.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/biologics-market

The therapeutic expansion of biologics across various indications such as asthma, allergic conditions, dyslipidemia and other non-traditional disease areas attributed to the forecasted growth. However, the expedited expansion of biosimilars has a negative impact on the overall growth of biologics market. Biosimilars being cost-effective with similar efficacy would gain higher demand in developing countries. Biologics approved in the U.S comprise longer patent protection in comparison to those approved in Europe. Additionally, EMA has less stringent policies for biosimilars in comparison to the U.S FDA, thus North America owns larger market share than Europe and will maintain its dominance throughout the forecast period. Growing prevalence of cancer, autoimmune diseases & diabetes, presence of leading market players, and continuous research activities drive the North American market. Asia Pacific is the fastest growing market accounting to double digit CAGR during the forecast period. Expansion of international players in developing nations contribute to the biologics market growth in this region. Novartis AG wishes to launch its FDA approved treatment Kymriah in Japan. However, discussions on the pricing of the treatment in Japan is still under negotiations with Ministry of Health, and Labor & Welfare (MHLW).

Biologics entering the market contest with similar indications and with more or less similar mechanism of action. Biologics market is thus highly competitive comprising established and leading market players such as Abbvie, Inc., Amgen, Inc., AstraZeneca Plc., Celgene Corporation, Janssen Pharmaceuticals, Inc., Merck & Co. Inc., Novartis AG, Pfizer, Inc., Roche Holding AG, Sanofi S.A and Takeda Pharmaceutical Co., Ltd.

Key Market Movements:

  • Globally, biologics market continues to witness a lucrative growth with a CAGR of 9.5% for the period from 2018 to 2026
  • Presence of an extensive product portfolio and above 800 pipeline molecules, contributed to the overall growth of the market
  • Among all the products available, recombinant therapeutic proteins maintains dominancy comprehending larger market share during the period from 2016 to 2026
  • The introduction of new cellular and gene therapy namely CAR-T cell provides better therapeutic outcome. Furthermore, research activities in this area contributes to the overall market growth during the forecast period.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59079

Table of Content

Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I-Secondary Research
1.4.2. Phase II-Primary Research
1.4.3. Phase III-Expert Panel Review
1.4.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Biologics Market Portraiture
2.2. Global Biologics Market, by Product, 2017 (US$ Bn)
2.3. Global Biologics Market, by Disease, 2017 (US$ Bn)
2.4. Global Biologics Market, by Geography, 2017 (US$ Bn)

Chapter 3. Global Biologics Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Growing Prevalence Of Chronic Conditions
3.2.1.2. Increased Investment in Research Activities
3.2.2. Market Challenges
3.2.2.1. Growth of Biosimilars
3.2.2.2. Challenge 2
3.2.3. Market Opportunities
3.2.3.1. Strong Pipeline Candidates
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Biologics Market, by Product, 2016-2026 (US$ Bn)
4.1. Overview
4.2. Recombinant Therapeutic Proteins
4.2.1. Monoclonal Antibodies
4.2.2. Hormones
4.2.3. Cytokines
4.2.4. Enzymes
4.3. Blood & Blood components
4.4. Cellular & Gene Therapy
4.5. Vaccines

Chapter 5. Global Biologics Market, by Disease, 2016-2026 (US$ Bn)
………….

Chapter 6. Global Biologics Market, by Geography, 2016-2026 (US$ Bn)
……………

Blog Medium: https://medium.com/@kumarganesh028/biologics-market-9-5-cagr-2018-to-2026-global-industry-size-share-growth-trends-and-forecast-2f3442b6eb18

Find more research reports on Pharmaceuticals Industry, by Credence Research

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Drone Simulator Software Market Size, Share, Growth, Trends, Analysis and Forecast 2018 to 2026

November 13, 2019 by Johnson Paul  

According to a new market research report published by Credence Research “Drone Simulator Software Market (Operating System – Windows, Mac and Linux; Application – Defense & Law Enforcement and Commercial) – Growth, Future Prospects and Competitive Analysis, 2018 – 2026”, the global drone simulator software market is estimated to grow at a CAGR of 17.2% during the forecast period from 2018 to 2026.

Market Insights

Drones have emerged one of the most dynamic and promising sectors over the past few years. The overall industry sales is expected to hit 3 Mn units by the end of 2018, creating immense opportunities for adjacent markets such as drone simulator software. Apart from defense sector, drones are now rapidly gaining pace in commercial and personal sectors. Nevertheless, due to significantly higher cost of these drones, training forms a very crucial part for consumers willing to pilot a drone. Considering the complexity and difficulty associated with drone flying and control, drone simulator has gained immense importance over the past few years.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/drone-simulator-software-market

The overall drone simulator software market is primarily driven by the increasing consumption of drones worldwide. Since 2013, the total drones units sold has more than quadrupled, thereby driving the simulator software market significantly. The demand for drones has increased exponentially across applications such as surveillance, photography, delivery and sports among others. This has further increased the need for related flight training, thereby impacting the drone simulation market growth positively. Moreover, ease of installing these software onto one’s computer makes its adoption even more popular. Training can be controlled using existing gears such as keyboards, mouse or joysticks, making drone simulator convenient and cost-effective.

The overall drone simulator software market is categorized on the basis of operating system and application. Based on operating system, the market is classified into Windows, Mac and Linux. In terms of application, the market has been categorized into defense & law enforcement and commercial. In 2017, defense & law enforcement segment led the market accounting for more than 65% of the total market value worldwide. On the basis of geography, the market is led by North America contributing to more than 30% of the overall market value. The market is primarily driven by the presence of huge drones industry here. In addition, huge success and ever growing popularity of the Drone Racing League (DRL), a professional drone racing league in the U.S., is further aiding the market growth here.

Some of the major players profiled in the report are Aegis Technologies, CAE, Inc., Zen Technologies Ltd., Leonardo S.p.A., HELI-X, Selex ES, RealFlight Software, ImmersionRC Ltd., L-3 Link Simulation & Training and Hotprops among others.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59044

Table of Content

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Market Segmentation
1.4 Research Methodology
1.4.1 Phase I – Secondary Research
1.4.2 Phase II – Primary Research
1.4.3 Phase III – Expert Panel Review
1.4.4 Assumptions
1.4.5 Approach Adopted

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Drone Simulator Software Market
2.2 Global Drone Simulator Software Market, By Operating System
2.3 Global Drone Simulator Software Market, By Application
2.4 Global Drone Simulator Software Market, By Geography

Chapter 3 Market Dynamics
3.1 Market Overview
3.1.1 Global Drone Simulator Software Market Value and Growth, 2016 – 2026, (US$ Mn)
3.2 Market Drivers
3.3 Market Growth Inhibitors
3.3.1 Impact Analysis of Drivers and Restraints
3.4 Key Market Trends and Future Outlook
3.5 Attractive Investment Proposition
3.6 Competitive Analysis
3.6.1 Market Positioning of Key Vendors
3.6.2 Key Strategies Adopted by the Leading Players

Chapter 4 Global Drone Simulator Software Market Analysis, by Operating System
4.1 Market Analysis
4.2 Windows
4.3 Mac
4.4 Linux

Chapter 5 Global Drone Simulator Software Market Analysis, by Application
5.1 Market Analysis
5.2 Defense & Law Enforcement
5.3 Commercial

Chapter 6 North America Drone Simulator Software Market Analysis
…………

Chapter 7 Europe Drone Simulator Software Market Analysis
………….

Chapter 8 Asia Pacific Drone Simulator Software Market Analysis
…………..

Chapter 9 Rest of the World (RoW) Drone Simulator Software Market Analysis
…………….

Blog Medium: https://medium.com/@kumarganesh028/drone-simulator-software-market-17-2-d55e3688cc3f

Find more research reports on Aerospace & Defense Industry, by Credence Research

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Epigenetics Market Size, Share, Growth, Trends, Analysis and Forecast 2018 to 2026

November 12, 2019 by Johnson Paul  

According to the latest market report published by Credence Research, Inc. “Epigenetics Market By Product (Kits, Reagent, Enzymes, Instruments and Bioinformatics Tools), By Technology (DNA Methylation, Histone Modification and Other), By Application (Cancer, Metabolic Diseases, Immune Diseases, Cardiovascular Diseases and Other) - Growth, Future Prospects and Competitive Analysis, 2018 - 2026” the global epigenetics market was valued at US$ 4.63 Bn in 2017, and is expected to reach US$ 16.50 Bn by 2026, expanding at a CAGR of 15.03 % from 2018 to 2026.   

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/epigenetics-market

Market Insights

Epigenetics is a relatively new science in the broader field of genetics, and involves the study of the chemical modification of specific genes or gene-associated proteins. These epigenetic changes do not involve changes in the actual DNA sequence. For the purpose of the study, epigenetics market is segmented into product types such as kits (ChiP-Seq Kits, whole-genome amplification kits, 5-HMC and 5-MC analysis kits and other epigenetics kits), reagents, enzymes (DNA-modifying enzymes, protein-modifying enzymes and RNA-modifying enzymes), instruments and bioinformatics tools. Currently, the demand for kits is highest in the market and anticipated to exhibits fastest market growth over the forecast period. Continuous advancement in the nature and precision of testing kits, rising prevalence of different diseases, wide availability of robust, simple-to-use, and cost-efficient kits, and increasing application of epigenetic technologies in research laboratories are the factors that catalyze the overall market growth.

The global epigenetics market is segmented on the basis of technologies such as DNA methylation, histone modification and other techniques. DNA methylation is most widely accepted technology as it has great potential in the field of personalized drug development and understanding the functional mechanisms in complex disease cases. Epigenetics have application in cancer, metabolic diseases, immune diseases, cardiovascular diseases and other areas. Cancer application held largest market share in the base year 2017, because epigenetic alterations are essential in the cellular transformation to cancer, and their manipulation holds great potential in cancer detection, prevention and therapy.

North America is the current leader in global epigenetics market and expected to show dominance over the forecast period. Higher acceptance of newer technologies, enormous investment in R&D, and developed healthcare infrastructure are the key factors contributing to the dominance of this region. On the other hand, Asia Pacific is projected to show fastest market growth over the forecast period primarily due to increasing healthcare spending and developing healthcare infrastructure. Significant CRO activities in hubs such as India also feature the rapid pace of Asia Pacific market.

Market Competition Assessment:

The epigenetics market is highly competitive owing to the presence of market players across geographies with investments in research activities. The market  currently is dominated by few key manufacturers such as Abcam, Plc., Active Motif, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Diagenode, Inc., Illumina, Inc., Merck & Co., Inc., New England Biolabs Inc., Perkinelmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Zymo Research Corp. and others.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59026

Table of Content

Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Phase III-Expert Panel Review
1.3.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Epigenetics Market Portraiture
2.2. Global Epigenetics Market, by Product, 2017 (US$ Mn)
2.3. Global Epigenetics Market, by Technology, 2017 (US$ Mn)
2.4. Global Epigenetics Market, by Application, 2017 (US$ Mn)
2.5. Global Epigenetics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Epigenetics: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Challenges
3.2.3. Opportunities
3.3. Attractive Investment Proposition: Epigenetics Market, by Geography, 2017
3.4. Competitive Analysis of Key Players in Epigenetics Market, 2017

Chapter 4. Global Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Kits
4.2.1. ChiP-Seq Kits
4.2.2. Whole-Genome Amplification Kits
4.2.3. 5-HMC and 5-MC Analysis Kits
4.2.4. Other Epigenetics Kits
4.3. Reagents
4.4. Enzymes
4.4.1. DNA-Modifying Enzymes
4.4.2. Protein-Modifying Enzymes
4.4.3. RNA-Modifying Enzymes
4.5. Instruments
4.6. Bioinformatics Tools

Chapter 5. Global Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. DNA Methylation
5.3. Histone Modification
5.4. Other Techniques

Chapter 6. Global Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. Cancer
6.3. Metabolic Diseases
6.4. Immune Diseases
6.5. Cardiovascular Diseases
6.6. Others

Chapter 7. Global Epigenetics Market, by Geography, 2016 – 2026 (US$ Mn)
…………..

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/epigenetics-market

Find more research reports on Medical Devices Industry, by Credence Research

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com